Status Epilepticus Clinical Trial
— SMARTEROfficial title:
Smartphone Medical Applications to Reduce Treatment Dosage Errors in Pediatric Resuscitation; a Randomized Simulation Trial
Verified date | October 2017 |
Source | St. Justine's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Medication errors are common in children. Characteristics of errors during critical
situations in the Emergency Department are ill-defined and might be more frequent than
previously thought. However, optimal strategies to eliminate the risk of prescribing errors
remain unknown.
Many smartphone apps have been suggested over the last years with some of them designed to
calculate medication dosage for children. The impact of these apps to decrease dosage error
has never been evaluated in resuscitation setting.
The aim of the study is to evaluate whether the use of a smartphone application designed to
calculate medication doses decreases prescribing errors among residents during pediatric
simulated resuscitations.
This will be a crossover-randomized trial using high fidelity simulation among 40 residents
rotating in the pediatric emergency department.
Status | Completed |
Enrollment | 40 |
Est. completion date | September 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Residents (PGY1 to PGY4) - Completing a rotation in pediatric emergency Exclusion Criteria: - Residents who previously participated in this study |
Country | Name | City | State |
---|---|---|---|
Canada | CHU Sainte-Justine | Montreal | Quebec |
Lead Sponsor | Collaborator |
---|---|
St. Justine's Hospital | Canadian Medical Protective Association |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Medication error | The primary outcome is the presence of a medication error. An error will be defined as a drug dose varying by more than 20% from the recommended dose or by incorrect route. | During resuscitation | |
Secondary | Proportion of tenfold error | A tenfold error will be defined as a drug dose varying by a factor of 10 compared to the recommended dose. | During resuscitation | |
Secondary | Time for prescribing the first medication | Time from the beginning of the simulation and complete prescription (oral or written) of the first medication. | During the simulation (10 minutes) | |
Secondary | Error in bolus medication | An error in bolus medication will be defined as a drug dose varying by more than 20% from the recommended dose or by incorrect route. | during simulation | |
Secondary | Error in perfusion medication | An error in perfusion medication will be defined as a drug dose varying by more than 20% from the recommended dose. This can be related to a preparation error or a flow error. | during simulation | |
Secondary | User satisfaction | Satisfaction of the resident with both tools using a Visual analog scale | 2 weeks | |
Secondary | User confidence | Confidence of the resident while using both tools using a Visual analog scale | 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03883516 -
Improving Emergency Management of Status Epilepticus
|
N/A | |
Recruiting |
NCT03378687 -
A Clinical Study of Children With Status Epilepticus in China
|
N/A | |
Recruiting |
NCT00362141 -
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
|
Phase 2 | |
Recruiting |
NCT05140265 -
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
|
||
Active, not recruiting |
NCT04391569 -
Randomized Therapy In Status Epilepticus
|
Phase 3 | |
Recruiting |
NCT06017973 -
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 | |
Recruiting |
NCT05491590 -
Patient-reported Outcome After Status Epilepticus
|
||
Recruiting |
NCT04421846 -
Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
|
N/A | |
Completed |
NCT02239380 -
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
|
Phase 3 | |
Completed |
NCT01796574 -
Ketogenic Diet for Refractory Status Epilepticus
|
N/A | |
Completed |
NCT02381977 -
Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment
|
N/A | |
Completed |
NCT00004297 -
Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus
|
Phase 3 | |
Completed |
NCT03905798 -
LORA-PITA IV General Investigation
|
||
Recruiting |
NCT05591508 -
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
|
N/A | |
Completed |
NCT00735527 -
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children
|
Phase 3 | |
Terminated |
NCT00265616 -
Treatment of Refractory Status Epilepticus
|
Phase 3 | |
Recruiting |
NCT06401707 -
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
|
Phase 2 | |
Enrolling by invitation |
NCT06403150 -
The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus
|
Phase 4 | |
Recruiting |
NCT05246566 -
Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana
|